BR112014015124A2 - agente de imagiologia; composto; composição farmacêutica; kit; método de formação de imagens de um coração em um paciente; e kit de diagnóstico - Google Patents
agente de imagiologia; composto; composição farmacêutica; kit; método de formação de imagens de um coração em um paciente; e kit de diagnósticoInfo
- Publication number
- BR112014015124A2 BR112014015124A2 BR112014015124A BR112014015124A BR112014015124A2 BR 112014015124 A2 BR112014015124 A2 BR 112014015124A2 BR 112014015124 A BR112014015124 A BR 112014015124A BR 112014015124 A BR112014015124 A BR 112014015124A BR 112014015124 A2 BR112014015124 A2 BR 112014015124A2
- Authority
- BR
- Brazil
- Prior art keywords
- imaging
- compound
- kit
- patient
- heart
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 238000003384 imaging method Methods 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 238000009007 Diagnostic Kit Methods 0.000 title abstract 2
- 239000012216 imaging agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002059 diagnostic imaging Methods 0.000 abstract 1
- 230000002107 myocardial effect Effects 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161579113P | 2011-12-22 | 2011-12-22 | |
| SE1151249 | 2011-12-22 | ||
| PCT/SE2012/051421 WO2013095273A1 (en) | 2011-12-22 | 2012-12-18 | Contrast agent for imagining myocardial perfusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014015124A2 true BR112014015124A2 (pt) | 2017-06-13 |
Family
ID=48668967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014015124A BR112014015124A2 (pt) | 2011-12-22 | 2012-12-18 | agente de imagiologia; composto; composição farmacêutica; kit; método de formação de imagens de um coração em um paciente; e kit de diagnóstico |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9295738B2 (enExample) |
| EP (1) | EP2793952B1 (enExample) |
| JP (1) | JP6140187B2 (enExample) |
| KR (1) | KR101931792B1 (enExample) |
| CN (1) | CN104114191A (enExample) |
| AU (1) | AU2012354223B2 (enExample) |
| BR (1) | BR112014015124A2 (enExample) |
| CA (1) | CA2859773C (enExample) |
| ES (1) | ES2687234T3 (enExample) |
| IL (1) | IL233219A (enExample) |
| MX (1) | MX356258B (enExample) |
| RU (1) | RU2629840C2 (enExample) |
| SG (1) | SG11201403429YA (enExample) |
| WO (1) | WO2013095273A1 (enExample) |
| ZA (1) | ZA201405199B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9955876B2 (en) * | 2016-09-08 | 2018-05-01 | Raul Chirife | Device and method for assessment of left ventricular ejection fraction and other parameters of cardiac performance |
| CN107233585B (zh) * | 2017-06-09 | 2021-01-22 | 四川大学华西医院 | 黄连素或其衍生物在制备心肌灌注显像剂中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344702B2 (en) * | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| US7932272B2 (en) * | 2003-09-30 | 2011-04-26 | Eisai R&D Management Co., Ltd. | Antifungal agent containing heterocyclic compound |
| US7824659B2 (en) * | 2005-08-10 | 2010-11-02 | Lantheus Medical Imaging, Inc. | Methods of making radiolabeled tracers and precursors thereof |
| US8415333B2 (en) | 2009-02-24 | 2013-04-09 | Respiratorious Ab | Bronchodilating diazaheteroaryls |
-
2012
- 2012-12-18 WO PCT/SE2012/051421 patent/WO2013095273A1/en not_active Ceased
- 2012-12-18 KR KR1020147018989A patent/KR101931792B1/ko not_active Expired - Fee Related
- 2012-12-18 RU RU2014125849A patent/RU2629840C2/ru active
- 2012-12-18 MX MX2014007491A patent/MX356258B/es active IP Right Grant
- 2012-12-18 EP EP12858896.9A patent/EP2793952B1/en not_active Not-in-force
- 2012-12-18 SG SG11201403429YA patent/SG11201403429YA/en unknown
- 2012-12-18 CN CN201280069796.5A patent/CN104114191A/zh active Pending
- 2012-12-18 AU AU2012354223A patent/AU2012354223B2/en not_active Ceased
- 2012-12-18 ES ES12858896.9T patent/ES2687234T3/es active Active
- 2012-12-18 CA CA2859773A patent/CA2859773C/en active Active
- 2012-12-18 JP JP2014548735A patent/JP6140187B2/ja not_active Expired - Fee Related
- 2012-12-18 US US14/367,520 patent/US9295738B2/en not_active Expired - Fee Related
- 2012-12-18 BR BR112014015124A patent/BR112014015124A2/pt not_active Application Discontinuation
-
2014
- 2014-06-18 IL IL233219A patent/IL233219A/en active IP Right Grant
- 2014-07-16 ZA ZA2014/05199A patent/ZA201405199B/en unknown
-
2015
- 2015-12-17 US US14/972,127 patent/US9687565B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HK1201459A1 (en) | 2015-09-04 |
| AU2012354223A1 (en) | 2014-07-03 |
| AU2012354223B2 (en) | 2017-03-16 |
| SG11201403429YA (en) | 2014-07-30 |
| CA2859773C (en) | 2020-09-01 |
| US9295738B2 (en) | 2016-03-29 |
| EP2793952A1 (en) | 2014-10-29 |
| CA2859773A1 (en) | 2013-06-27 |
| KR101931792B1 (ko) | 2019-03-13 |
| ES2687234T3 (es) | 2018-10-24 |
| MX356258B (es) | 2018-05-16 |
| US9687565B2 (en) | 2017-06-27 |
| RU2014125849A (ru) | 2016-02-10 |
| ZA201405199B (en) | 2015-12-23 |
| MX2014007491A (es) | 2015-02-17 |
| JP6140187B2 (ja) | 2017-05-31 |
| WO2013095273A1 (en) | 2013-06-27 |
| JP2015500873A (ja) | 2015-01-08 |
| KR20140107411A (ko) | 2014-09-04 |
| EP2793952A4 (en) | 2015-09-09 |
| EP2793952B1 (en) | 2018-06-13 |
| US20160101195A1 (en) | 2016-04-14 |
| IL233219A0 (en) | 2014-08-31 |
| IL233219A (en) | 2016-08-31 |
| RU2629840C2 (ru) | 2017-09-04 |
| US20140341808A1 (en) | 2014-11-20 |
| CN104114191A (zh) | 2014-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014004336A2 (pt) | sistema e método para estimar a quantidade de interesse de um sistema de artéria / tecido / veia dinâmico | |
| BR112014018561A8 (pt) | Anticorpo; ácido nucleico; célula hospedeira; composição farmacêutica; uso de um anticorpo; método para produção de um anticorpo; e método para produção de uma linhagem celular que produz um anticorpo | |
| BR112012017994B8 (pt) | composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio | |
| BRPI0917315B8 (pt) | anticorpo monoclonal, seu uso e composição farmacêutica o compreendendo | |
| SV2011003939A (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
| BR112013014914B8 (pt) | composto, composição farmacêutica e uso de um composto | |
| MX2013011921A (es) | Compuestos de benceno substituidos con arilo o heterorilo. | |
| BR112015025140A2 (pt) | 2-fenilimidazo[1,2-a]pirimidinas como agentes de imagem | |
| UY32970A (es) | Acidos 3-fenilpropionicos sustituidos y su uso | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| MY174894A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation | |
| PA8794401A1 (es) | Acidos 6-fenilnicotinicos sustituidos y su uso | |
| EA201100301A1 (ru) | Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения | |
| BRPI0507684A (pt) | agentes de contraste para formação de imagem de perfusão miocárdica | |
| SV2016005153A (es) | Compuestos y composiciones como inhibidores de la mek | |
| BR112015021596A2 (pt) | moduladores de gpr120 de ácido oxabiciclo[2.2.2] | |
| EA201391525A1 (ru) | Гликозидные производные и их применение для лечения диабета | |
| EP4327886A3 (en) | Pyrimido- pyridazinone compounds and use thereof | |
| CL2009001240A1 (es) | Compuestos derivados del acido l-glutamico y l-glutamina marcados con [f-18]; procedimiento de preparacion; composicion farmaceutica que comprende a los compuestos y su uso como agentes en el diagnostico de tumores. | |
| BR112014011223A2 (pt) | método de tratar uma doença proliferativa | |
| BR112014012892A2 (pt) | agentes de reversão anticoagulantes | |
| BR112012027648A2 (pt) | composto medicamento, método para profilaxia ou tratamento de doença, e, uso de composto | |
| BR112015004523A2 (pt) | compostos de tetraciclina | |
| BR112013024606A2 (pt) | composição, kit farmacêutico, e, métodos para o tratamento de uma condição de pele, e para preparar uma composição | |
| BR112015004643A2 (pt) | métodos e composições para ressucitação hipotensiva |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |